Scott Van Winkle

Shares of Herbalife Ltd. (NYSE: HLF) have risen steadily so far in 2015 and are up 46 percent year-to-date. Canaccord Genuity’s Scott Van Winkle maintained a Buy rating on the company, with a price target of $58. Greater-than-expected cost control is expected to boost the company...

In a report rolled out Monday, Canaccord analysts Scott Van Winkle and Mark Sigal reiterated a Buy rating on Hain Celestial Group Inc (NASDAQ: HAIN), while boosting their price target from $69.00 to $73.00. The price target bump responds to the “efficient tuck-in acquisition” of Mona...

In a report published Tuesday, Canaccord Genuity analyst Scott Van Winkle maintained a Buy rating on shares of United Natural Foods, Inc. (NASDAQ: UNFI) with a price target slashed to $71 from a previous $85 due to the "increasingly competitive" retail environment that is further challenging growth...

The top three analysts for Keurig Green Mountain Inc (NASDAQ: GMCR) were listed by TipRanks recently. Each of the three had more than 4 stars, with John Staszak at Argus Research the most highly rated of the top three. Staszak rated Keurig Green Mountain a Buy and maintained a $164 price...

Canaccord Genuity on Thursday issued a company update on Herbalife Ltd. (NYSE: HLF) ahead of the company's earnings announcement on May 5. Canaccord maintained its Buy rating and raised the price target from $42 to $50. Analysts Scott Van Winkle and Mark Sigal wrote, "The Q1 results, particularly...

Whole Foods Market, Inc.'s (NASDAQ: WFM) scale should enable it to prosper in an increasingly competitive market while higher spending will result in continued earnings growth, an analyst said Tuesday. The Austin, Texas-based retailer has gained about 4 percent since it posted earnings last...

In a report published Monday, Canaccord Genuity analyst Scott Van Winkle wrote that shares of Herbalife Ltd. (NYSE: HLF) are starting to feel like a "value trap" but are still undervalued. Van Winkle noted the company's fourth quarter report showed sales and volume growth came in...

Canaccord lowered its price target on Nu Skin Enterprises, Inc. (NYSE: NUS) from $53 to $45 on Thursday and maintained a Hold rating. The change comes after the company lowered its forecast for Q4. Analyst Scott Van Winkle believed “a stabilization and month-over-month growth in China are...

On Thursday, Canaccord analyst Scott Van Winkle offered his thoughts on the FTC investigation of Herbalife (NYSE: HLF), which should not be a “major surprise.” Van Winkle believes the FTC investigation could hang over Herbalife for 9 to 10 months citing an investigation of similar charges against...

In a report published Tuesday, Canaccord Genuity analyst Scott Van Winkle initiated coverage on Enzymotec Ltd. (NASDAQ: ENZY) with a Buy rating and $24.00 price target. In the report, Canaccord Genuity noted, “We believe Enzymotec is well positioned to drive sustained growth in the highly...

In a report published Wednesday, Canaccord Genuity analyst Scott Van Winkle reiterated a Buy rating on Nu Skin (NYSE: NUS), and raised the price target from $66.00 to $83.00. In the report, Canaccord Genuity noted, “Our thesis remains that Nu Skin is in the midst of a powerful product cycle,...